RBC Capital Maintains Outperform on Johnson & Johnson, Raises Price Target to $290

Benzinga Newsdesk www.benzinga.com Positive 90.8%

Neg 0% Neu 0% Pos 90.8%

RBC Capital analyst Trung Huynh maintains Johnson & Johnson (NYSE:JNJ) with a Outperform and raises the price target from $287 to $290.